Anocca AB
556946-2384ActiveEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Clinical-stage Biopharmaceutical Companyanocca.com
Yleiskatsaus
- 100–199
- Työntekijät
- 750–999t SEK
- Liikevaihto
- 2013
- Perustettu
Avainpäättäjät
Jacob Michlewicz
Chief Financial Officer
@anocca.com+46731XXXXXX
Niclas Sandberg
Head of Quality Control
@anocca.com
Mattias Persson
Head of Engineering
@anocca.com
Mikael Blomqvist
Board Member
@anocca.com
+34 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Anocca AB is a fully integrated, clinical-stage biopharmaceutical company based in Sweden. The organization specializes in creating libraries of T-cell receptor-engineered T cell (TCR-T) therapies. Their core mission is to redefine the treatment landscape for solid tumors, as well as infectious and...
Valo Therapeutics Oy